Search Results - "Abastado, Jean‐Pierre"

Refine Results
  1. 1

    Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor by Toh, Benjamin, Wang, Xiaojie, Keeble, Jo, Sim, Wen Jing, Khoo, Karen, Wong, Wing-Cheong, Kato, Masashi, Prevost-Blondel, Armelle, Thiery, Jean-Paul, Abastado, Jean-Pierre

    Published in PLoS biology (01-09-2011)
    “…In order to metastasize, cancer cells need to acquire a motile phenotype. Previously, development of this phenotype was thought to rely on the acquisition of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy by Chew, Valerie, Toh, Han Chong, Abastado, Jean-Pierre

    Published in Journal of Oncology (01-01-2012)
    “…The tumor microenvironment plays a critical role in cancer development, progression, and control. The molecular and cellular nature of the tumor immune…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Macrophage polarization to a unique phenotype driven by B cells by Wong, Siew-Cheng, Puaux, Anne-Laure, Chittezhath, Manesh, Shalova, Irina, Kajiji, Tasneem S, Wang, Xiaojie, Abastado, Jean-Pierre, Lam, Kong-Peng, Biswas, Subhra K

    Published in European journal of immunology (01-08-2010)
    “…Regulation of adaptive immunity by innate immune cells is widely accepted. Conversely, adaptive immune cells can also regulate cells of the innate immune…”
    Get full text
    Journal Article
  6. 6

    Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D by Tan, Kar Wai, Chong, Shu Zhen, Wong, Fiona H.S., Evrard, Maximilien, Tan, Sandra Min-Li, Keeble, Jo, Kemeny, D.M., Ng, Lai Guan, Abastado, Jean-Pierre, Angeli, Véronique

    Published in Blood (21-11-2013)
    “…Lymphangiogenesis is an important physiological response to inflammatory insult, acting to limit inflammation. Macrophages, dendritic cells, and lymphocytes…”
    Get full text
    Journal Article
  7. 7

    TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression by Ho, Victor, Lim, Tong Seng, Lee, Justin, Steinberg, Jeffrey, Szmyd, Radoslaw, Tham, Muly, Yaligar, Jadegoud, Kaldis, Philipp, Abastado, Jean-Pierre, Chew, Valerie

    Published in Oncotarget (29-09-2015)
    “…Hepatocellular carcinoma (HCC) is associated with high mortality and the current therapy for advanced HCC, Sorafenib, offers limited survival benefits. Here we…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma by Tham, Muly, Khoo, Karen, Yeo, Kim Pin, Kato, Masashi, Prevost-Blondel, Amelle, Angeli, Veronique, Abastado, Jean-Pierre

    Published in Oncotarget (08-09-2015)
    “…Surgical resection of tumors is often followed by regrowth at the primary site and metastases may emerge rapidly following removal of the primary tumor…”
    Get full text
    Journal Article
  10. 10

    Mapping of HPV transcripts in four human cervical lesions using RNAseq suggests quantitative rearrangements during carcinogenic progression by Chen, Jinmiao, Xue, Yuezhen, Poidinger, Michael, Lim, Thimothy, Chew, Sung Hock, Pang, Chai Ling, Abastado, Jean-Pierre, Thierry, Françoise

    Published in Virology (New York, N.Y.) (01-08-2014)
    “…Abstract Two classes of Human papillomaviruses (HPV) infect the anogenital track: high risk viruses that are associated with risk of cervical cancer and low…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Expansion of cortical and medullary sinuses restrains lymph node hypertrophy during prolonged inflammation by Tan, Kar Wai, Yeo, Kim Pin, Wong, Fiona H S, Lim, Hwee Ying, Khoo, Kai Ling, Abastado, Jean-Pierre, Angeli, Véronique

    Published in The Journal of immunology (1950) (15-04-2012)
    “…During inflammation, accumulation of immune cells in activated lymph nodes (LNs), coupled with a transient shutdown in lymphocyte exit, results in dramatic…”
    Get full text
    Journal Article
  13. 13

    Covert Human Immunodeficiency Virus Replication in Dendritic Cells and in DC-SIGN-Expressing Cells Promotes Long-Term Transmission to Lymphocytes by NOBILE, Cinzia, PETIT, Caroline, MORIS, Arnaud, SKRABAL, Katharina, ABASTADO, Jean-Pierre, MAMMANO, Fabrizio, SCHWARTZ, Olivier

    Published in Journal of Virology (01-05-2005)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14

    Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands by Chew, Valerie, Abastado, Jean-Pierre

    Published in Oncoimmunology (01-04-2013)
    “…In hepatocellular carcinoma (HCC) patients, the intratumoral expression of Toll-like receptor-3 (TLR3) correlates with prolonged survival. We demonstrated that…”
    Get full text
    Journal Article
  15. 15

    Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma Lesions by Nardin, Alessandra, Wong, Wing-Cheong, Tow, Charlene, Molina, Thierry Jo, Tissier, Frédérique, Audebourg, Anne, Garcette, Marylene, Caignard, Anne, Avril, Marie-Francoise, Abastado, Jean-Pierre, Prévost-Blondel, Armelle

    Published in Journal of investigative dermatology (01-09-2011)
    “…Dacarbazine (DTIC) is the standard first-line drug for advanced stage melanoma, but it induces objective clinical responses in only 15% of patients. This study…”
    Get full text
    Journal Article
  16. 16

    In silico modeling of cancer cell dissemination and metastasis by Wai, Lu-En, Narang, Vipin, Gouaillard, Alexandre, Ng, Lai Guan, Abastado, Jean-Pierre

    Published in Annals of the New York Academy of Sciences (01-05-2013)
    “…Metastasis is the main cause of cancer‐related death. It is surprising then that the exact nature of metastasis—the process by which cancer cells leave the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The Next Challenge in Cancer Immunotherapy: Controlling T-Cell Traffic to the Tumor by ABASTADO, Jean-Pierre

    Published in Cancer research (Chicago, Ill.) (01-05-2012)
    “…One of the steps that limits the efficacy of T-cell-based immunotherapy of cancer is T-cell access to the tumor. We recently showed that several…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma by Pin, Yeo Kim, Khoo, Karen, Tham, Muly, Karwai, Tan, Hwee, Thiam Chung, Puaux, Anne-Laure, Phua, Meow Ling Cindy, Kato, Masashi, Angeli, Veronique, Abastado, Jean-Pierre

    Published in Oncotarget (29-12-2015)
    “…Resection of infiltrated tumor-draining lymph nodes (TDLNs) is a standard practice for the treatment of several cancers including breast cancer and melanoma…”
    Get full text
    Journal Article